Home > Compound List > Product Information
Metyrapone_Molecular_structure_CAS_54-36-4)
Click picture or here to close

Metyrapone

Catalog No. M2696 Name Sigma Aldrich
CAS Number 54-36-4 Website http://www.sigmaaldrich.com
M. F. C14H14N2O Telephone 1-800-521-8956
M. W. 226.27376 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 884

SYNONYMS

IUPAC name
2-methyl-1,2-bis(pyridin-3-yl)propan-1-one
IUPAC Traditional name
metyrapone
Synonyms
2-甲基-1,2-二-3-吡啶基-1-丙酮
美替拉酮
2-Methyl-1,2-di-3-pyridyl-1-propanone
Su-4885
Metyrapone

DATABASE IDS

Beilstein Number 163023
CAS Number 54-36-4
EC Number 200-206-2
MDL Number MFCD00006397

PROPERTIES

Empirical Formula (Hill Notation) C14H14N2O
Purity ≥98% (HPLC)
Apperance solid
Flash Point >110 °C
Flash Point >230 °F
Melting Point 52-55 °C(lit.)
Solubility H2O: <2 mg/mL
Solubility DMSO: >20 mg/mL
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H302-H315-H319-H335
European Hazard Symbols Harmful Harmful (Xn)
MSDS Link Download
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Gloves
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 22-36/37/38
RTECS UC3050000
Safety Statements 26
Storage Temperature room temp
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
Metyrapone is a glucocorticoid synthesis inhibitor; a standard in assessing adrenal gland function especially in response to stress, as well as pituitary gland function. In addition to acting as a glucocorticoid synthesis inhibitor, Metyrapone also inhibits cytochrome P450-mediated prostaglandin ω/ω-1 hydroxylase activity and impairs learning and memory. Data shows results in activation of the sleep EEG and a robust decrease in quantitative delta sleep.
Description (简体中文)
Biochem/physiol Actions
Metyrapone is a glucocorticoid synthesis inhibitor; a standard in assessing adrenal gland function especially in response to stress, as well as pituitary gland function. In addition to acting as a glucocorticoid synthesis inhibitor, Metyrapone also inhibits cytochrome P450-mediated prostaglandin ω/ω-1 hydroxylase activity and impairs learning and memory. Data shows results in activation of the sleep EEG and a robust decrease in quantitative delta sleep.

REFERENCES